Sentinel lymph node mapping in colorectal cancer;Le ganglion sentinelle dans les cancers du côlon et du rectum

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 2, 2003, Pages 204-211

  Tuech, Jean Jacques ^a   Regenet, Nicolas ^a   Ollier, Jean Claude ^a   Rodier, Jean François ^a  

^a CENTRE PAUL STRAUSS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; COLORECTAL CANCER; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENTINEL LYMPH NODE;

COLORECTAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; SENTINEL LYMPH NODE BIOPSY;

EID: 17644433139     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
2. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
3. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-8.
4. Liptay MJ, Masters GA, Winchester DJ, Edelman BL, Garrido BJ, Hirschtritt TR, et al. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg 2000;70: 384-9.
5. Rodier JF, Janser JC, Routiot T, David E, Ott G, Schneegans O, et al. Sentinel node biopsy in vulvar malignancies: a preliminary feasibility study. Oncol Rep 1999;6:1249-52.
6. Rodier JF, Janser JC, David E, Routiot T, Ott G. Radiopharmaceutical-guided surgery in primary malignant melanoma of the vagina. Gynecol Oncol 1999;75:308-9.
7. Wawroschek F, Vogt H, Weckermann D, Wagner T, Harzmann R. The sentinel lymph node concept in prostate can. Eur Urol 1999;36:595-600.
8. Arch-Ferrer J, Velazquez D, Fajardo R, Gamboa-Dominguez A, Herrera MF. Accuracy of sentinel lymph node in papillary thyroid carcinoma. Surgery 2001;130:907-13.
9. Waters GS, Geisinger KR, Garske DD, Loggie BW, Levine EA. Sentinel lymph node mapping for carcinoma of the colon: a pilot study. Am Surg 2000;66:943-5.
10. Sanson M. Fait remarquable de diathése cancéreuse. Gaz Med Paris 1834;2:140.
11. Saphir O, Amromin G. Obscure axillary lymph node metastasis in carcinoma of the breast. Cancer 1948;1:238-41.
12. Friedman S, Bertin F, Mouriesse H, Benchabat A, Genin J, Sarrazin D, et al. Importance of tumor cells in axillary node sinus margins ('clandestine'metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol 1988;27:483-7.
13. Rosen PP, Saigo PE, Braun DW, Jr., Beattie EJ, Jr., Kinne DW. Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli. Am J Surg Pathol 1982;6:639-41.
14. Wong LS, Cantrill JE, Odogwu S, Morris AG, Fraser IA. Detection of circulating tumour cells and nodal metastasis by reverse transcriptasepolymerase chain reaction technique. Br J Surg 1997;84:834-9.
15. Koch M, Weitz J, Kienle P, Benner A, Willeke F, Lehnert T, et al. Comparative analysis of tumor cell dissemination in mesenteric, central, and peripheral venous blood in patients with colorectal cancer. Arch Surg 2001;136:85-9.
16. Huvos AG, Hutter RV, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971;173: 44-6.
17. Sobin LH, Wittekind C. TNM: classification des tumeurs malignes. Séme ed. Cassini, Paris: 1998.
18. Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999;86:2668-73.
19. Sobin LH. Frequently asked questions regarding the application of the TNM classification. TNM/Prognostic Factors Project (International Union Against Cancer [UICC]). Cancer 1999;85:1405-6.
20. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995;55:3417-20.
21. van Diest PJ, Peterse HL, Borgstein PJ, Hoekstra O, Meijer CJ. Pathological investigation of sentinel lymph nodes. Eur J Nucl Med 1999;26:S43-S49.
22. Messina JL, Glass LF, Cruse CW, Berman C, Ku NK, Reintgen DS. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol 1999;23:686-90.
23. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
24. Rodier JF, Routiot T, Mignotte H, Janser JC, Bremond A, David E, et al. Lymphatic mapping and sentinel node biopsy of operable breast cancer. World J Surg 2000;24:1220-5.
25. Abati A, Liotta LA. Looking forward in diagnostic pathology: the molecular superhighway. Cancer 1996;78:1-3.
26. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-8.
27. Soeth E, Roder C, Juhl H, Kruger U, Kremer B, Kalthoff H. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer 1996;69:278-82.
28. Brugger W, Buhring HJ, Grunebach F, Vogel W, Kaul S, Muller R, et al. Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J Clin Oncol 1999;17:1535-44.
29. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;71:278-81.
30. Launoy G, Grosclaude P, Pienkowski P, Faivre J, Menegoz F, Schaffer P, et al. Comparaison de l'incidence dans 7 départements et estimation de l'incidence pour la France entière. Gastroenterol Clin Biol 1992;16:633-8.
31. Pillon D, Boutron MC, Arveux P, Milan C, Bedenne L, Hillon P, et al. L'incidence du cancer colorectal dans le département de la Cote-d'Or entre 1976 and 1985. Gastroenterol Clin Biol 1989;13:860-4.
32. Prandi M, Lionetto R, Bini A, Francioni G, Accarpio G, Anfossi A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg 2002;235:458-63.
33. Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994;73:2076-82.
34. Jeffers MD, O'Dowd GM, Mulcahy H, Stagg M, O'Donoghue DP, Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994;172:183-7.
35. Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes'B colorectal carcinoma: an immunohistochemical study. Eur J Surg 1996;162:637-42.
36. O'Brien MJ, Zamcheck N, Burke B, Kirkham SE, Saravis CA, Gottlieb LS. Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues. Assessment of diagnostic value. Am J Clin Pathol 1981;75:283-90.
37. Sasaki M, Watanabe H, Jass JR, Ajioka Y, Kobayashi M, Matsuda K, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in « node-negative » colorectal cancer. J Gastroenterol 1997;32:758-64.
38. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW, Jr. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994;73:563-9.
39. Broll R, Schauer V, Schimmelpenning H, Strik M, Woltmann A, Best R, et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study. Dis Colon Rectum 1997;40:1465-71.
40. Cutait R, Alves VA, Lopes LC, Cutait DE, Borges JL, Singer J, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991;34:917-20.
41. Oberg A, Stenling R, Tavelin B, Lindmark G. Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum 1998;41:1244-9.
42. Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 2001;8:300-4.
43. Choi HJ, Choi YY, Hong SH. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma. Dis Colon Rectum 2002;45:750-5.
44. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998;153:865-73.
45. Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes'B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 1998;83:666-72.
46. Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind C. TNM atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. 4th edition. Berlin: Springer, 1997.
47. Consensus conference: Prevention Screening and Management of the Colonic Cancers. Paris, France, January 29-30, 1998. Proceedings. Gastroenterol Clin Biol 1998;22:S1-295.
48. Miles WE. A method of performing abdomino-perineal excision for carcinoma of the rectum and the terminal portion of the pelvic colon. Lancet 1908;2:1812-16.
49. Lasser P, Elias D. Généralités sur la chirurgie d'exérèse des cancers coliques. Problèmes techniques généraux et stratégie thérapeutique. Encycl Med Chir (Elsevier, Paris), Techniques chirurgicales-Appareil digestif, 40-555, 1996, 8p.
50. Koren R, Siegal A, Klein B, Halpern M, Kyzer S, Veltman V, et al. Lymph node-revealing solution: simple new method for detecting minute lymph nodes in colon carcinoma. Dis Colon Rectum 1997;40:407-10.
51. Arav E, Picot M, De La Tour Du Pin, Yaziji N, Majek E, Patey M, et al. Comment optimiser la dissection des ganglions lymphatiques dans les carcinomes colorectaux. Une technique de clarification simple et efficace. Ann Pathol 1999;19:147-50.
52. Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 1989;7:1447-56.
53. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
54. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA. The intergroup study of fluorouracil (5FU) plus levamisole (Lev) and levamisole alone as an adjuvant therapy for stade C colon cancer. A final report. Proc Am Soc Clin Oncol 1992;161-8.
55. Merrie AE, van Rij AM, Phillips LV, Rossaak JI, Yun K, Mccall JL. Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 2001;44:410-7.
56. Cserni G, Vajda K, Tarjan M, Bori R, Svebis M, Baltas B. Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathol Oncol Res 1999;5:291-6.
57. Esser S, Reilly WT, Riley LB, Eyvazzadeh C, Arcona S. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum 2001;44:850-4.
58. Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK, et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 2000;7:120-4.
59. Saha S, Bilchik A, Wiese D, Espinosa M, Badin J, Ganatra BK, et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping techniquea multicenter trial. Ann Surg Oncol 2001;8:94S-8S.
60. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999;86:482-6.
61. Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W, Jr., et al. Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 2001;8:150-7.
62. Wood TF, Spirt M, Rangel D, Shen P, Tsioulias GJ, Morton DL, et al. Lymphatic mapping improves staging during laparoscopic colectomy for cancer. Surg Endosc 2001;15:715-9.
63. Wong JH, Steineman S, Calderia C, Bowles J, Namiki T. Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg 2001;233:515-21.
64. Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-11.
65. Paramo JC, Summerall J, Wilson C, Cabral A, Willis I, Wodnicki H, et al. Intraoperative sentinel lymph node mapping in patients with colon cancer. Am J Surg 2001;182:40-3.
66. Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 2001;19:1128-36.
67. Wood TF, Nora DT, Morton DL, Turner RR, Rangel D, Hutchinson W, et al. One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: detection of missed micrometastases. J Gastrointest Surg 2002;6:322-9.
68. Grinnell RS. Lymphatic block with atypical and retrograde lymphatic metastasis and spread in carcinoma of the colon and rectum. Ann Surg 1966;163:272-80.
69. Fitzgerald TL, Khalifa MA, Al Zahrani M, Law CH, Smith AJ. Ex vivo sentinel lymph node biopsy in colorectal cancer: a feasibility study. J Surg Oncol 2002;80:27-32.
70. Bilchik AJ, Nora D, Tollenaar RA, van de Velde CJ, Wood T, Turner R, et al. Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer 2002;38:977-85.
71. Arnaud JP, Adloff M, Schloegel M, Haegele P, Grobbe JC. Un progrès dans l'évaluation de l'extension ganglionnaire des cancers du rectum: la lymphoscintigraphie rectale endoscopique. J Chir (Paris) 1989;126: 179-82.
72. Cutini G, Gesuelli GC, Sartelli M, Brianzoni E, Musolino G, Nestori M, et al. The role of lymphoscintigraphy in rectal laparoscopic surgery: can the sentinel node concept be applied to rectal carcinoma? Surg Endosc 2001;15:1440-3.
73. Steup WH, Moriya Y, van de Velde CJ. Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer 2002;38:911-8.
74. Bilchik AJ, Saha S, Tsioulias GJ, Wood TF, Morton DL. Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms. Ann Surg Oncol 2001;8:82S-5S.